Mirwais Wardak retweeted
Back with another interview! Loved talking w @HimanshuNagarMD re: navigating job search, early career advice, building meaningful research collabs & more.
Recommend listening for residents & junior faculty esp now during interview season.
Full video link below. TY, Himanshu!
Mirwais Wardak retweeted
App period for the Cedars-Sinai PhD Program in Health AI is now OPEN! Come study cutting-edge AI in a top hospital with clinical rotations, clinical collaborators, & easy access to clinical data - please RT! cedars-sinai.edu/education/g… #artificialintelligence #bioinformatics #phd
Mirwais Wardak retweeted
A personal story behind a professional mission. In @UTSWMedCenter's Unscripted, our Chief of Breast Radiation Oncology Service, Dr. @AsalRahimiMD, shares how losing her mother to breast cancer inspired her work to improve treatment for women everywhere.
youtube.com/watch?v=smYZ6shi…
Mirwais Wardak retweeted
New research led by Dr. @AmarUKishan shows combining PSMA-targeted radioligand therapy with SBRT reduces recurrent prostate cancer progression risk by 62%.
By targeting visible tumors & microscopic cells, it delays the need for hormone therapy.
ucla.in/4iicLnT
Mirwais Wardak retweeted
Engineering T cells for immunotherapy vs cancer had already had marked success in certain types. But there's a next generation in the hopper, as reviewed today @Cancer_Cell, that ought to help take the field much further into solid tumors
cell.com/cancer-cell/fulltex…
Mirwais Wardak retweeted
ASTRO 2026 News Roundup:
Potential Role of Low-Dose Radiation Therapy in Managing Knee Osteoarthritis: zurl.co/vP9TP
Study Shows Fractionated Radiosurgery Improves Local Control in Post-Surgery Treatment for Large Brain Metastases: zurl.co/zMoyk
Five-Treatment SBRT Demonstrates Long-Term Effectiveness for Localized Prostate Cancer: zurl.co/4yMlS
Stereotactic Radiosurgery Demonstrates Potential in Treating Severe Depression: zurl.co/sm6PM
Ultra-Low-Dose Radiation Therapy Assessed for Bone Pain Relief in Multiple Myeloma Patients: zurl.co/kAuRZ
#RadOnc #RadOncNews #RadiationOncology #CancerCare #ASTRO26
Mirwais Wardak retweeted
In a new Science study, researchers present the Virtual Biotech, a multi-agent AI system to inform drug-development decisions.
By combining diverse biomedical and clinical evidence in a unified platform, the system may help identify therapeutic opportunities that would otherwise be missed.
Learn more: scim.ag/46WEiVK
Mirwais Wardak retweeted
🎉 Sharing our latest @JClinicalInvest review. We propose coupling BIOLOGICAL twin (iPSC, organoids) & DIGITAL twin (clinical, multiomics) for cardiometabolic drug development.
@StanfordMed @StanfordCVI @GreenstoneBio @Stanford_ChEMH @StanfordDeptMed
jci.org/articles/view/209668
Mirwais Wardak retweeted
Today, we're excited to share that Biomni is published in @ScienceMagazine.
Biomedical research is still fragmented, manual, and difficult to scale. In this work, we introduce Biomni - the first general-purpose biomedical AI agent with an integrated biology environment that can reason, plan, and execute end-to-end scientific workflows.
We show that, with the right environment and harness, AI can automate large-scale omics analyses, orchestrate laboratory robotics, optimize molecular properties, and even train new AI models for biology.
We also introduce a reinforcement learning recipe for continually improving biomedical AI agents, enabling open-source models to achieve frontier-level performance.
It's surreal to look back. We started the Biomni project in early 2024, when agentic AI was still nascent. It is exciting to see tens of thousands of biologists collaborating with agents every day to accelerate science.
Try Biomni: biomni.phylo.bio
Read more: science.org/doi/10.1126/scie…
This work is not possible without this truly inter-disciplinary team: @serena2z @hcwww_ @YuanhaoQ Minta Lu, Ryan Li, @yusufroohani Lin Qiu @shiyi_c98 Gavin Junze Di @rickwierenga @kavi_deniz Sherry @TianweiShe Shruti Jennefer Xin Zhou @MWheelerMD Jon Bernstein @MengdiWang10 @PengHeAtlas @zhou_jingtian @SnyderShot @lecong Aviv Regev @jure
@StanfordAILab @genentech @phylo_bio @arcinstitute @UW @berkeley_ai @RetroBio_ @tamarindbio @Princeton @UCSF
Hearts from young donors age rapidly in the bodies of older recipients, and older hearts are rejuvenated inside young people
go.nature.com/4rzzsHf
Mirwais Wardak retweeted
📚Jin Q, Wan N, Leaman R, Tian S, Wang Z, Yang Y, et al. Tutorial: guidance on the use of large language models for medical research. 2026.
@NatureProtocols
🔗nature.com/articles/s41596-0…
#InteligenciaArtificial #InvestigaciónMédica
Mirwais Wardak retweeted
Novartis secures new radioligand in $900M deal fiercebiotech.com/biotech/no…
Mirwais Wardak retweeted
Melbourne, Australia-based pharmaceutical company Telix has received U.S. FDA approval for Pixclara, making it the first FDA-approved PET imaging agent for glioma.
Read the full story 👇 buff.ly/rcexph3
#Radiology #MedicalImaging #DiagnosticImaging
Mirwais Wardak retweeted
How regular exercise enhances our immune response.
A multiomic blood assessment (single-cell RNA, epigenetics, metabolites, lipids, and cells) with distinct signature for exercise vs sedentary lifestyle @ScienceAdvances
science.org/doi/10.1126/scia…
Mirwais Wardak retweeted
n/
Try out #VirtualBiotech here virtualbiotech.ai/
Paper: science.org/doi/10.1126/scie…
Non-paywall: biorxiv.org/content/10.64898…
Code: github.com/harrisongzhang/Th…
Great job @harrison_zhang Peter Eckmann @Jiacheng_Miao and Andy Mahon!
Mirwais Wardak retweeted
Design, simulate, refine: simulation-guided clinical trials for accelerated drug development
rdcu.be/ftz8C
nature.com/articles/s41573-0…
This new Perspective discusses the value of trial simulations, presents best-practice recommendations and describes case studies of impact
Mirwais Wardak retweeted
Super excited that #VirtualBiotech is published in @ScienceMagazine today!
Tens of thousands of AI scientist agents work together across drug discovery + development, from target discovery to clinical trial design. Our blueprint for agentic R&D 🧵
"We want to see how far these agent teams of AI scientists can help us to really accelerate drug discovery and development”
go.nature.com/4AhkF8d
The JNM Theranostics Supplement is out now! Join Johannes Czernin, JNM Editor-in-Chief, for a highlight reel of what to expect from the issue. Read the full supplement here: jnm.snmjournals.org/content/…





























